Clinical Trials Directory

Trials / Completed

CompletedNCT00638677

Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
106 (actual)
Sponsor
University of Turku · Academic / Other
Sex
All
Age
1 Month – 4 Years
Healthy volunteers
Accepted

Summary

Aims: 1. To develop a food supplement containing a health-promoting probiotic bacteria (B. lactis BB12) and xylitol to be administered with a novel soft, possibly occlusion-friendly pacifier. 2. Test in a clinical study how feasible the method is and to study how the intervention affects caries occurrence. Main hypothesis: The administration of B. lactis BB12 and xylitol affects beneficially the dental health of the child.

Detailed description

Xylitol is known to reduce counts of mutans streptococci (ms) as well as mother-child transmission of ms. Possibly xylitol delivered to infants could positively influence colonization/metabolism of ms. By combining in a food supplement xylitol and B. lactis BB12 (a well known probiotic bacteria) we may be able to positively affect both gut and oral colonization, reflected in both dental and general health (solid data available on the latter aim). Though B. lactis is in wide use in baby formulas and in in vitro tests it apparently is safe for the teeth, no clinical studies have looked at effects of its administration to infants on oral health. Our study aims to look at caries occurrence in infants who have received the xylitol + BB12 food supplement with a pacifier. Recruiting of subjects to the study is completed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSorbitolSorbitol tablet delivered with a slow-release pacifier starting 1 mo after delivery and lasting max 2 years
DIETARY_SUPPLEMENTXylitol + BB12Xylitol + BB12 tablet delivered with a slow-release pacifier starting 1 mo after delivery and continuing max 2 years
DIETARY_SUPPLEMENTXylitolXylitol+BB 12 delivery with a pacifier max until 2 years

Timeline

Start date
2004-06-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2008-03-19
Last updated
2013-01-08

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00638677. Inclusion in this directory is not an endorsement.